Anteris Technologies Global Corp. (AVR)
NASDAQ
Real-time Data
01:30 PM
Day's Range
6.5752 wk Range
3.30Overview - AVR - Anteris Technologies Global Corp.
Key Statistics
Valuation
Enterprise Value
492.29M
P/E (Trailing)
‪-3.02‬
P/E (Forward)
‪-7.69‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪333.88‬
Price / Book
‪2.97‬
EV / EBITDA
‪-4.71‬
Profitability
Gross Margin
‪76.90%‬
Profit Margin
‪70.25%‬
Operating Margin
‪-3,072.05%‬
Return on Assets
‪-42.50%‬
Return on Equity
‪-74.65%‬
Ownership
Shares Outstanding
97.41M
Float
65.97M
Short % of Shares Outstanding
‪9.41%‬
Held by Insiders
‪16.47%‬
Held by Institutions
‪71.02%‬
Price stats
50-Day Avg
‪8.56‬
200-Day Avg
‪7.17‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪$ 15.33‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AVR - Anteris Technologies Global Corp.
Peers - AVR - Anteris Technologies Global Corp.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- AVRNASDAQAnteris Technologies Ltd.748.56MMarket Cap+43.30%52-week change-3.02P/E (Trailing)‪70.25%‬Profit Margin
- ISRGNASDAQIntuitive Surgical Inc.140.42BMarket Cap-14.73%52-week change45.00P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc. Class A Common Stock47.91BMarket Cap-15.14%52-week change44.51P/E (Trailing)‪2.31%‬Profit Margin
- COONASDAQThe Cooper Companies, Inc.10.82BMarket Cap-23.20%52-week change19.56P/E (Trailing)‪13.46%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.10.42BMarket Cap+13.90%52-week change25.53P/E (Trailing)‪9.99%‬Profit Margin
- RGENNASDAQRepligen Corporation10.25BMarket Cap+17.39%52-week change248.90P/E (Trailing)‪5.29%‬Profit Margin
- MMEDNASDAQMiniMed Group, Inc.5.54BMarket Cap+6.14%52-week change-15.16P/E (Trailing)‪-9.74%‬Profit Margin
Profile Summary - AVR - Anteris Technologies Global Corp.
About
Anteris Technologies Ltd. is a structural heart company that designs, develops, and commercializes innovative medical devices for treating heart valve diseases. Its flagship product, the DurAVR Transcatheter Heart Valve system, features a single-piece, native-shaped biomimetic design engineered to mimic the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
